OTCMKTS:OMRX

Orthometrix - OMRX Stock Forecast, Price & News

Add

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Orthometrix

Orthometrix, Inc. engages in the marketing, sale, and servicing of musculoskeletal product lines used in research, diagnostic, and monitoring of bone and muscle disorders, sports medicine, rehabilitative medicine, physical therapy, fitness, and pain management. It has developed and acquired the rights to technologies, procedures, and devices to assess musculoskeletal conditions, help restore mobility following orthopedic or neurological trauma, maintain or increase musculoskeletal performance, and help delay the adverse effect on mobility of certain medical conditions like Parkinson's or diabetic neuropathy. The company was founded by Reynald G. Bonmati in December 1993 and is headquartered in Naples, FL.

Receive OMRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthometrix and its competitors with MarketBeat's FREE daily newsletter.

OMRX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive OMRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthometrix and its competitors with MarketBeat's FREE daily newsletter.

OMRX Company Calendar

Today: 3/25/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Analytical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:OMRX
CUSIP: N/A
CIK: N/A
Web: www.orthometrix.net
Phone: (914) 694-5946
Fax: 914-694-2286
Employees: 7
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Reynald G. Bonmati (Age 73)
Founder, Chief Exec. Officer, Pres, Treasurer and Chairman

Mr. Arik Avni B.Sc. (Age 61)
M.Sc., PT, Chief Technical Officer

Key Competitors

View All Competitors

OMRX Stock - Frequently Asked Questions

What is Orthometrix's stock symbol?: Orthometrix trades on the OTCMKTS under the ticker symbol "OMRX."
How do I buy shares of Orthometrix?: Shares of OMRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
How can I contact Orthometrix?: Orthometrix's mailing address is 106 CORPORATE PARK DRIVE SUITE 106, WHITE PLAINS NY, 10604. The official website for the company is www.orthometrix.net. The company can be reached via phone at (914) 694-5946 or via fax at 914-694-2286.

This page (OTCMKTS:OMRX) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial